Finance

Beta
Lists
TTI:CVE
Thiogenesis Therapeutics Corp
CA$0.60
0.00%
(0.00) 1D
Jun 2, 10:44:07 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for TTI...
Mkt. cap
31.10M
Avg. vol.
24.72K
Volume
0.00
52-wk high
CA$0.88
52-wk low
CA$0.44
EPS
-CA$0.14
Beta
9.62
Shares outstanding
51.84M
Mkt. cap
31.10M
Avg. vol.
24.72K
Volume
0.00
52-wk high
CA$0.88
52-wk low
CA$0.44
EPS
-CA$0.14
Beta
9.62
Shares outstanding
51.84M
News stories
From sources across the web
About Thiogenesis Therapeutics Corp
CEO-
Employees-
Founded2018
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websitethiogenesis.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.47M
1.92M
1.27M
579.55K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
368.80K
471.84K
464.40K
338.28K
Operating expense
1.83M
2.39M
1.73M
917.82K
Total operating expenses
1.83M
2.39M
1.73M
917.82K
Operating income
-1.83M
-2.39M
-1.73M
-917.82K
Other non operating income
-
-
-
-
EBT including unusual items
-1.90M
-2.38M
-1.73M
-911.82K
EBT excluding unusual items
-1.90M
-2.38M
-1.73M
-911.82K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.90M
-2.38M
-1.73M
-911.82K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
11.01K
6.45K
4.42K
51.00
Interest expense
-
-
-
-
Net interest expenses
11.01K
6.45K
4.42K
51.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer